Differences in place of death between lung cancer and COPD patients: A 14-country study using death certificate data

Joachim Cohen, Kim Beernaert, Lieve Van Den Block, Lucas Morin, Katherine Hunt, Guido Miccinesi, Marylou Cardenas-Turanzas, Bregje Onwuteaka-Philipsen, Rod MacLeod, Miguel Ruiz-Ramos, Donna M. Wilson, Martin Loucka, Agnes Csikos, Yong Joo Rhee, Joan Teno, Winne Ko, Luc Deliens, Dirk Houttekier

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Chronic obstructive pulmonary disease and lung cancer are leading causes of death with comparable symptoms at the end of life. Cross-national comparisons of place of death, as an important outcome of terminal care, between people dying from chronic obstructive pulmonary disease and lung cancer have not been studied before. We collected population death certificate data from 14 countries (year: 2008), covering place of death, underlying cause of death, and demographic information. We included patients dying from lung cancer or chronic obstructive pulmonary disease and used descriptive statistics and multivariable logistic regressions to describe patterns in place of death. Of 5,568,827 deaths, 5.8% were from lung cancer and 4.4% from chronic obstructive pulmonary disease. Among lung cancer decedents, home deaths ranged from 12.5% in South Korea to 57.1% in Mexico, while hospital deaths ranged from 27.5% in New Zealand to 77.4% in France. In chronic obstructive pulmonary disease patients, the proportion dying at home ranged from 10.4% in Canada to 55.4% in Mexico, while hospital deaths ranged from 41.8% in Mexico to 78.9% in South Korea. Controlling for age, sex, and marital status, patients with chronic obstructive pulmonary disease were significantly less likely die at home rather than in hospital in nine countries. Our study found in almost all countries that those dying from chronic obstructive pulmonary disease as compared with those from lung cancer are less likely to die at home and at a palliative care institution and more likely to die in a hospital or a nursing home. This might be due to less predictable disease trajectories and prognosis of death in chronic obstructive pulmonary disease.

Original languageEnglish (US)
Article number41533
Journalnpj Primary Care Respiratory Medicine
Volume27
Issue number1
DOIs
StatePublished - Dec 1 2017
Externally publishedYes

Fingerprint

Death Certificates
Chronic Obstructive Pulmonary Disease
Lung Neoplasms
Mexico
Republic of Korea
Cause of Death
Terminal Care
Marital Status
Nursing Homes
Palliative Care
New Zealand
France
Canada
Logistic Models
Demography

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Public Health, Environmental and Occupational Health

Cite this

Differences in place of death between lung cancer and COPD patients : A 14-country study using death certificate data. / Cohen, Joachim; Beernaert, Kim; Van Den Block, Lieve; Morin, Lucas; Hunt, Katherine; Miccinesi, Guido; Cardenas-Turanzas, Marylou; Onwuteaka-Philipsen, Bregje; MacLeod, Rod; Ruiz-Ramos, Miguel; Wilson, Donna M.; Loucka, Martin; Csikos, Agnes; Rhee, Yong Joo; Teno, Joan; Ko, Winne; Deliens, Luc; Houttekier, Dirk.

In: npj Primary Care Respiratory Medicine, Vol. 27, No. 1, 41533, 01.12.2017.

Research output: Contribution to journalArticle

Cohen, J, Beernaert, K, Van Den Block, L, Morin, L, Hunt, K, Miccinesi, G, Cardenas-Turanzas, M, Onwuteaka-Philipsen, B, MacLeod, R, Ruiz-Ramos, M, Wilson, DM, Loucka, M, Csikos, A, Rhee, YJ, Teno, J, Ko, W, Deliens, L & Houttekier, D 2017, 'Differences in place of death between lung cancer and COPD patients: A 14-country study using death certificate data', npj Primary Care Respiratory Medicine, vol. 27, no. 1, 41533. https://doi.org/10.1038/s41533-017-0017-y
Cohen, Joachim ; Beernaert, Kim ; Van Den Block, Lieve ; Morin, Lucas ; Hunt, Katherine ; Miccinesi, Guido ; Cardenas-Turanzas, Marylou ; Onwuteaka-Philipsen, Bregje ; MacLeod, Rod ; Ruiz-Ramos, Miguel ; Wilson, Donna M. ; Loucka, Martin ; Csikos, Agnes ; Rhee, Yong Joo ; Teno, Joan ; Ko, Winne ; Deliens, Luc ; Houttekier, Dirk. / Differences in place of death between lung cancer and COPD patients : A 14-country study using death certificate data. In: npj Primary Care Respiratory Medicine. 2017 ; Vol. 27, No. 1.
@article{526bda69926041c28be430efd7c259b2,
title = "Differences in place of death between lung cancer and COPD patients: A 14-country study using death certificate data",
abstract = "Chronic obstructive pulmonary disease and lung cancer are leading causes of death with comparable symptoms at the end of life. Cross-national comparisons of place of death, as an important outcome of terminal care, between people dying from chronic obstructive pulmonary disease and lung cancer have not been studied before. We collected population death certificate data from 14 countries (year: 2008), covering place of death, underlying cause of death, and demographic information. We included patients dying from lung cancer or chronic obstructive pulmonary disease and used descriptive statistics and multivariable logistic regressions to describe patterns in place of death. Of 5,568,827 deaths, 5.8{\%} were from lung cancer and 4.4{\%} from chronic obstructive pulmonary disease. Among lung cancer decedents, home deaths ranged from 12.5{\%} in South Korea to 57.1{\%} in Mexico, while hospital deaths ranged from 27.5{\%} in New Zealand to 77.4{\%} in France. In chronic obstructive pulmonary disease patients, the proportion dying at home ranged from 10.4{\%} in Canada to 55.4{\%} in Mexico, while hospital deaths ranged from 41.8{\%} in Mexico to 78.9{\%} in South Korea. Controlling for age, sex, and marital status, patients with chronic obstructive pulmonary disease were significantly less likely die at home rather than in hospital in nine countries. Our study found in almost all countries that those dying from chronic obstructive pulmonary disease as compared with those from lung cancer are less likely to die at home and at a palliative care institution and more likely to die in a hospital or a nursing home. This might be due to less predictable disease trajectories and prognosis of death in chronic obstructive pulmonary disease.",
author = "Joachim Cohen and Kim Beernaert and {Van Den Block}, Lieve and Lucas Morin and Katherine Hunt and Guido Miccinesi and Marylou Cardenas-Turanzas and Bregje Onwuteaka-Philipsen and Rod MacLeod and Miguel Ruiz-Ramos and Wilson, {Donna M.} and Martin Loucka and Agnes Csikos and Rhee, {Yong Joo} and Joan Teno and Winne Ko and Luc Deliens and Dirk Houttekier",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41533-017-0017-y",
language = "English (US)",
volume = "27",
journal = "npj Primary Care Respiratory Medicine",
issn = "2055-1010",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Differences in place of death between lung cancer and COPD patients

T2 - A 14-country study using death certificate data

AU - Cohen, Joachim

AU - Beernaert, Kim

AU - Van Den Block, Lieve

AU - Morin, Lucas

AU - Hunt, Katherine

AU - Miccinesi, Guido

AU - Cardenas-Turanzas, Marylou

AU - Onwuteaka-Philipsen, Bregje

AU - MacLeod, Rod

AU - Ruiz-Ramos, Miguel

AU - Wilson, Donna M.

AU - Loucka, Martin

AU - Csikos, Agnes

AU - Rhee, Yong Joo

AU - Teno, Joan

AU - Ko, Winne

AU - Deliens, Luc

AU - Houttekier, Dirk

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Chronic obstructive pulmonary disease and lung cancer are leading causes of death with comparable symptoms at the end of life. Cross-national comparisons of place of death, as an important outcome of terminal care, between people dying from chronic obstructive pulmonary disease and lung cancer have not been studied before. We collected population death certificate data from 14 countries (year: 2008), covering place of death, underlying cause of death, and demographic information. We included patients dying from lung cancer or chronic obstructive pulmonary disease and used descriptive statistics and multivariable logistic regressions to describe patterns in place of death. Of 5,568,827 deaths, 5.8% were from lung cancer and 4.4% from chronic obstructive pulmonary disease. Among lung cancer decedents, home deaths ranged from 12.5% in South Korea to 57.1% in Mexico, while hospital deaths ranged from 27.5% in New Zealand to 77.4% in France. In chronic obstructive pulmonary disease patients, the proportion dying at home ranged from 10.4% in Canada to 55.4% in Mexico, while hospital deaths ranged from 41.8% in Mexico to 78.9% in South Korea. Controlling for age, sex, and marital status, patients with chronic obstructive pulmonary disease were significantly less likely die at home rather than in hospital in nine countries. Our study found in almost all countries that those dying from chronic obstructive pulmonary disease as compared with those from lung cancer are less likely to die at home and at a palliative care institution and more likely to die in a hospital or a nursing home. This might be due to less predictable disease trajectories and prognosis of death in chronic obstructive pulmonary disease.

AB - Chronic obstructive pulmonary disease and lung cancer are leading causes of death with comparable symptoms at the end of life. Cross-national comparisons of place of death, as an important outcome of terminal care, between people dying from chronic obstructive pulmonary disease and lung cancer have not been studied before. We collected population death certificate data from 14 countries (year: 2008), covering place of death, underlying cause of death, and demographic information. We included patients dying from lung cancer or chronic obstructive pulmonary disease and used descriptive statistics and multivariable logistic regressions to describe patterns in place of death. Of 5,568,827 deaths, 5.8% were from lung cancer and 4.4% from chronic obstructive pulmonary disease. Among lung cancer decedents, home deaths ranged from 12.5% in South Korea to 57.1% in Mexico, while hospital deaths ranged from 27.5% in New Zealand to 77.4% in France. In chronic obstructive pulmonary disease patients, the proportion dying at home ranged from 10.4% in Canada to 55.4% in Mexico, while hospital deaths ranged from 41.8% in Mexico to 78.9% in South Korea. Controlling for age, sex, and marital status, patients with chronic obstructive pulmonary disease were significantly less likely die at home rather than in hospital in nine countries. Our study found in almost all countries that those dying from chronic obstructive pulmonary disease as compared with those from lung cancer are less likely to die at home and at a palliative care institution and more likely to die in a hospital or a nursing home. This might be due to less predictable disease trajectories and prognosis of death in chronic obstructive pulmonary disease.

UR - http://www.scopus.com/inward/record.url?scp=85019681501&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019681501&partnerID=8YFLogxK

U2 - 10.1038/s41533-017-0017-y

DO - 10.1038/s41533-017-0017-y

M3 - Article

C2 - 28258277

AN - SCOPUS:85019681501

VL - 27

JO - npj Primary Care Respiratory Medicine

JF - npj Primary Care Respiratory Medicine

SN - 2055-1010

IS - 1

M1 - 41533

ER -